ClearAlpha Technologies’s Merck MRK Stock Holding History

ClearAlpha Technologies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,443	Closed	-$243K	–	90
2024 Q4	$243K	Buy	+2,443	New	+$252K	0.17%	54

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ClearAlpha Technologies's MRK Position: Q1 2025 in Review

ClearAlpha Technologies sold out of Merck (MRK) in Q1 2025, closing a stake of 2,443 shares — an estimated $243K sold.

ClearAlpha Technologies first reported a position in MRK in Q4 2024 and held it in 1 quarter. The position peaked at $243K in Q4 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

ClearAlpha Technologies reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
ClearAlpha Technologies sold 2,443 Merck shares in Q1 2025, an estimated $243K.
ClearAlpha Technologies first reported a position in Merck in Q4 2024 and held it in 1 quarter.
ClearAlpha Technologies's Merck position peaked at $243K in Q4 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on ClearAlpha Technologies's 13F filing for Q1 2025, filed 15 May 2025.